Skip to content
Review Open access

Evolution of artificial intelligence and machine learning in DILI toxicogenomics: from descriptive profiling to mechanistic insights

Aug 2026 · Frontiers in Pharmacology · Vol 17 · 0 citations · 63 references
Medicine

TL;DR

The synergy of AI and DILI toxicogenomics has transitioned the discipline from descriptive profiling toward mechanism-driven predictive toxicology, highlighting toxicogenomics as a primary driver of advancement in this field of high-dimensional omics research.

Abstract

Drug-induced liver injury (DILI) is a critical safety issue in drug development, characterized by its idiosyncratic nature, complex mechanisms, and poor predictability in standard preclinical models. High-dimensional omics strategies, particularly toxicogenomics, have attracted increased interest in addressing the complexity of hepatotoxicity, especially in the context of emerging artificial intelligence (AI) technologies. This review traces the evolution of AI and machine learning (ML) within DILI-related omics research, highlighting toxicogenomics as a primary driver of advancement in this field. We first explore the early studies in computational toxicogenomics, which primarily focused on exploratory approaches, utilizing clustering, time-series, co-expression, and basic pathway analyses to identify molecular signatures indicative of nascent liver injury. We then examine how the adoption of supervised machine learning enabled robust predictive modeling, facilitating systematic feature selection, signature refinement, and rigorous validation. More recently, the field has been further transformed by deep learning, biologically informed network architectures, and generative artificial intelligence. Across these methodological eras, AI has enhanced mechanistic interpretation by identifying biologically relevant signatures, integrating multimodal evidence, and strengthening evidence for established DILI mechanisms, including oxidative stress, mitochondrial dysfunction, altered xenobiotic metabolism, inflammation, and cell death. Ultimately, the synergy of AI and DILI toxicogenomics has transitioned the discipline from descriptive profiling toward mechanism-driven predictive toxicology.

Read PDF

Similar papers

Review Oct 2026

Artificial Intelligence and machine learning in toxicogenomics for drug safety assessment: a critical review.

INTRODUCTION Predicting drug-induced toxicity remains one of the principal bottlenecks in drug development: in vivo and in vitro assays are resource-intensive, and their concordance with human-specific toxicity is often limited. Toxicogenomics addresses this gap by linking chemical exposure to gene-expression and pathw...

Baseerat Fatima, Minal Zaka, Maham Ashraf et al. · 0 citations
Review Open access Oct 2026

Artificial intelligence - driven toxicogenomics for predictive environmental and pharmaceutical safety

The significance of AI-based toxicogenomics in drug development, environmental contaminant screening, and regulatory toxicology, while addressing key challenges such as data heterogeneity, model interpretability, and regulatory acceptance is discussed.

Mohammed Monirul Islam, Sibghatullah Muhammad Ali Sangi, Girish Meravanige et al. · 0 citations
Open access Oct 2026

vToxiNet: An interpretable deep learning framework for hepatotoxicity prediction and mechanism exploration.

This study introduces the virtual toxicity network (vToxiNet), a biologically constrained deep learning framework that embeds systems toxicology knowledge directly into neural network architecture for interpretable hepatotoxicity prediction and supports further development of mechanism-informed approaches for chemical...

Xue-Lian Jia, Tong Wang, Daniel P. Russo et al. · 0 citations
Oct 2026

Advancing Drug Discovery via AI and In Silico Approaches

Artificial intelligence needs to be used to support instead of supplanting human expertise, supporting informed, patient-centered decision making and generating innovative, ethical healthcare solutions.

Prasad Hemant Mahajan, Mahalaxmi Mohan · 0 citations
#graph neural networks Review Open access Oct 2026

A review on advances in chemical compound toxicology prediction

The accurate prediction of chemical toxicity remains a major challenge in drug development and chemical safety assessment because conventional approaches can be costly, time-consuming, ethically constrained, and limited in predictive performance. This review examines how artificial intelligence (AI), particularly machi...

Ahmed Hagag, Nada A. Elsayed, Ibrahim Abdelbaky · 0 citations
Review Sep 2026

Harnessing Artificial Intelligence to Predict and Overcome Drug Resistance in Breast Cancer: A Translational Approach.

This review discusses how AI can accelerate computational drug discovery, virtual screening (VS), and the repurposing of already-approved medications, and it can also optimize combination therapies through computational simulation.

D. Bhagwat, Sonali A. Chikhalwale, S. Mali et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.